drugset / Trial / NCT01715311

Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control

NCT01715311 ↗

Phase 4 Withdrawn Novartis Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will compare the efficacy of indacaterol versus placebo (i.e., rescue medication only) and tiotropium in patients with Chronic Obstructive Pulmonary Disease (COPD) who have not received maintenance COPD medication for at least 12 months prior to entry (described hereafter as "maintenance naïve", see inclusion criteria).

Timeline

Start
2012-11
Primary completion
2013-09
Completion
2013-09

Outcome

Outcome not reported

Stopped (Enrollment): “withdrawn prior to patient recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Indacaterol Other / unclassified — Inhaled
Comparator Tiotropium Other / unclassified 18 ug Inhaled